Pfizer says its antiviral pill slashes risk of severe Covid-19 by 89%
Pfizer's pill, with the brand name Paxlovid, could secure US regulatory approval by the end of the year. Pfizer said it plans to submit interim trial results to the Food and Drug Administration (FDA) before the Nov. 25 US Thanksgiving holiday.
from Google Alert - Business https://ift.tt/305Ng43
Pfizer's pill, with the brand name Paxlovid, could secure US regulatory approval by the end of the year. Pfizer said it plans to submit interim trial results to the Food and Drug Administration (FDA) before the Nov. 25 US Thanksgiving holiday. https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/305Ng43
Pfizer's pill, with the brand name Paxlovid, could secure US regulatory approval by the end of the year. Pfizer said it plans to submit interim trial results to the Food and Drug Administration (FDA) before the Nov. 25 US Thanksgiving holiday. https://ift.tt/eA8V8J
Comments
Post a Comment